Pomerantz LLP has filed a class action lawsuit against zSpace, Inc. alleging securities fraud related to its December 2024 IPO. The lawsuit claims zSpace failed to disclose key information about preferred stock purchasers and potential litigation risks in its Registration Statement, misleading investors about the risk of lawsuits. Investors who bought zSpace securities during the class period can seek lead plaintiff status by June 22, 2026. The case highlights concerns about transparency and risk disclosure in zSpace's IPO process.
The FDA has accepted ImmunityBio's supplemental Biologics License Application (sBLA) for ANKTIVA to treat BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). This acceptance marks a key advancement for the company, with a PDUFA action date s...
Avaí Bio and Austrianova have completed a Master Cell Bank (MCB) of genetically modified cells that overexpress the α-Klotho protein, a key anti-aging protein. This milestone is crucial for producing consistent, safe cell-based therapies targeting ag...
The IT and digital infrastructure market is rapidly expanding due to increased enterprise spending on cloud computing, AI integration, cybersecurity, and managed services. The U.S. IT services market alone reached $405.7 billion in 2023 and is projec...
OpenAI and Google have significantly increased their AI investments in Singapore, establishing the city-state as a key AI hub in Asia-Pacific. OpenAI opened its first applied AI lab outside the U.S. in Singapore, backed by a S$300 million commitment,...
Holzer & Holzer, LLC announced approaching deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Vital Farms, Super Micro Computer, and Aldeyra Therapeutics. These lawsuits allege misleading statements or ...
